Zobrazeno 1 - 10
of 423
pro vyhledávání: '"Paulo M Hoff"'
Autor:
Renata Colombo Bonadio, Isadora Martins de Sousa, Flávia Cavalcanti Balint, Ana Carolina Marin Comini, Monique Celeste Tavares, Fernanda Madasi, Jose Bines, Rafael Dal Ponte Ferreira, Daniela Dornelles Rosa, Candice Lima Santos, Zenaide Silva de Souza, Daniele Assad-Suzuki, Júlio Antônio Pereira de Araújo, Débora de Melo Gagliato, Carlos Henrique dos Anjos, Bruna M. Zucchetti, Anezka Ferrari, Mayana Lopes de Brito, Renata Cangussu, Maria Marcela Fernandes Monteiro, Paulo M. Hoff, Laura Testa, Romualdo Barroso-Sousa
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-7 (2024)
Abstract Neoadjuvant pembrolizumab plus chemotherapy (P + CT) has emerged as a standard of care for stage II-III triple-negative breast cancer (TNBC). However, the best anthracycline-cyclophosphamide (AC) schedule remains to be determined. While the
Externí odkaz:
https://doaj.org/article/0b54a4ca94524373b724e7eccf37965d
Autor:
Cassio Murilo Hidalgo Filho, Felippe Lazar Neto, Vitor Pinheiro Sobottka, João Wilson da Rocha, Lucas Tadeu Barrak Stangler, Heloisa Guedes Andrade, Gustavo Benfatti Olivato, Mateus Zapparoli Claro, Danillo Zeferino de Oliveira Souza, Victor Junji Yamamoto, Mateus Marinho Nogueira Soares, Maria del Pilar Estevez-Diz, Paulo M. Hoff, Renata Colombo Bonadio
Publikováno v:
JCO Global Oncology, Vol , Iss 10 (2024)
PURPOSEMost patients with cancer will be hospitalized throughout the disease course. However, most evidence on the causes and outcomes of these hospitalizations comes from administrative data or small retrospective studies from high-income countries.
Externí odkaz:
https://doaj.org/article/d25ebcd7593943039efae7180f112f79
Autor:
João L Miraglia, Edson Abdala, Paulo M Hoff, André M Luiz, Danise S Oliveira, Carla G S Saad, Ieda M M Laurindo, Ana T R Viso, Angela Tayra, Lígia C Pierrotti, Luiz S Azevedo, Lúcia Maria A Campos, Nádia E Aikawa, Maria do Carmo S T Timenetsky, Expedito Luna, Maria Regina A Cardoso, José da S Guedes, Isaias Raw, Jorge Kalil, Alexander R Precioso
Publikováno v:
PLoS ONE, Vol 6, Iss 11, p e27214 (2011)
BackgroundImmunosuppressed individuals present serious morbidity and mortality from influenza, therefore it is important to understand the safety and immunogenicity of influenza vaccination among them.MethodsThis multicenter cohort study evaluated th
Externí odkaz:
https://doaj.org/article/a521253f5a8a48878f105bf9684f2625
Autor:
Everardo D Saad, Paulo M Hoff, Rosiléa P Carnelós, Artur Katz, Yana AS Novis, Marci Pietrocola, Nelson Hamerschlak, Jacques Tabacof, René C Gansl, Sergio D Simon
Publikováno v:
Revista Brasileira de Cancerologia, Vol 48, Iss 1 (2002)
Juntamente com a avaliação da eficácia de um determinado tratamento, a avaliação dos efeitos adversos conseqüentes a este tratamento representa um aspecto importante da análise do resultado terapêutico. O estudo quantitativo e qualitativo da
Externí odkaz:
https://doaj.org/article/e8152fbf30544e418072a9672ab87c6f
Autor:
Guilherme Nader Marta, Renata Colombo Bonadio, Odeli Nicole Encinas Sejas, Gabriel Watarai, Maria Cecilia Mathias Machado, Lorena Teixeira Frasson, Camila Motta Venchiarutti Moniz, Raquel Keiko de Luca Ito, Driele Peixoto, Camilla Oliveira Hoff, Veruska Menegatti Anastacio, Ulysses Ribeiro, Juliana Pereira, Vanderson Rocha, Edson Abdala, Maria Del Pilar Estevez-Diz, Paulo M. Hoff
Publikováno v:
JCO Global Oncology, Vol , Iss 7, Pp 1084-1092 (2021)
PURPOSEPatients with cancer are at increased risk for unfavorable outcomes from COVID-19. Knowledge about the outcome determinants of severe acute respiratory syndrome coronavirus 2 infection in this population is essential for risk stratification an
Externí odkaz:
https://doaj.org/article/e2217bc45bc8429d921404f56a00323a
Autor:
Diogo Turiani Hourneaux de Moura, Bruno Salomão Hirsch, Karina Gondim Moutinho da Conceição Vasconcelos, Luiz Tenório de Brito Siqueira, Saullo Queiroz Silveira, Eduardo Guimarães Hourneaux de Moura, Paulo M. Hoff
Publikováno v:
iGIE. 1:15-18
Autor:
Roberto J. Arai, Camila M.V. Moniz, André T.C. Chen, Milena P. Mak, Roger Chammas, Paulo M. Hoff
Publikováno v:
Contemporary Clinical Trials Communications, Vol 19, Iss , Pp 100637- (2020)
São Paulo city is the epicenter of the Brazilian COVID-19 pandemic. The Instituto do Cancer do Estado de São Paulo is currently conducting 161 multinational sponsored trials plus 116 in house studies in the oncologic population. There are 242 curre
Externí odkaz:
https://doaj.org/article/2861236644474214a94ded8b13493db1
Publikováno v:
Biomarker Research, Vol 6, Iss 1, Pp 1-6 (2018)
Abstract Metronomic therapy has been gaining importance in the neoadjuvant setting of breast cancer treatment. Its clinical benefits may involve antiangiogenic machinery. Cancer cells induce angiogenesis to support tumor growth by secreting factors,
Externí odkaz:
https://doaj.org/article/b27af46bb25c473f93a0548e50a5a8cf
Autor:
Josep Tabernero, Paulo M. Hoff, Lin Shen, Atsushi Ohtsu, Manish A. Shah, Asna Siddiqui, Sarah Heeson, Astrid Kiermaier, Harrison Macharia, Eleonora Restuccia, Yoon-Koo Kang
Publikováno v:
Scientia
Background Dual-targeted anti-HER2 therapy significantly improves outcomes in HER2-positive breast cancer and could be beneficial in other HER2-positive cancers. JACOB’s end-of study analyses aimed to evaluate the long-term efficacy and safety of p
Autor:
Carla Andressa Rodrigues Dias Fleury de Lima, Renata D'Alpino Peixoto, Rui F. Weschenfelder, Gabriel Prolla, Juliana F Rego, Duilio Rocha, Marcela Crosara, Gustavo Fernandes, Paulo M Hoff, Aline Chaves Andrade, Anelisa K. Coutinho, Rachel P. Riechelmann
Publikováno v:
Abordagens contemporâneas nas ciências da saúde vol.03 ISBN: 9786581028893
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::efc71ab68ae36e98f8dcbd3409b2f0cf
https://doi.org/10.35587/brj.ed.0002047
https://doi.org/10.35587/brj.ed.0002047